Overview
Compiles potential optimization questions countries may face for each vaccine in their portfolio, covering changes in product, presentation, schedule, composition and target population. Standardized fact sheets summarize expected benefits, programme implications, feasibility and proposed criteria for assessment. Countries can use it to review their portfolio vaccine by vaccine and identify the most relevant questions ahead of Workshop 1.
